FDA Orange Book · active-ingredient family
Doravirine
Doravirine is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PIFELTRO · NDA 210806
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PIFELTRORLD | MSD MERCK CO | NDA 210806 | — | Aug 30, 2018 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8486975 | Aug 30, 2032 | in 6 yr 3 mo | SubstanceProductU-2630 |
Doravirine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
